• Vitamin D/VDR Regulation of Endometrial Decidualization: New

  2026-05-04

  This study reveals that vitamin D, acting via its receptor (VDR), directly promotes endometrial stromal cell (ESC) decidualization by upregulating key markers and modulating estrogen biosynthesis pathways. These mechanistic insights advance understanding of endometrial receptivity and infertility, and provide a framework for modeling steroid hormone signaling in reproductive research.

• Practical Use of Annexin V-FITC/PI Apoptosis Assay Kit (K200

  2026-05-03

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, fluorescence-based discrimination of apoptotic and necrotic cells by detecting phosphatidylserine externalization and membrane integrity. It is best suited for research applications requiring clear staging of cell death, especially via flow cytometry or microscopy. This kit should not be used for clinical diagnostics or mechanistic claims beyond apoptosis stage identification.

• SU 5402: Unraveling Tyrosine Kinase Signaling in Disease Mod

  2026-05-02

  Explore how SU 5402, a potent receptor tyrosine kinase inhibitor, advances research in cancer biology and neuronal disease models. This article uncovers unique mechanistic insights and practical protocols, differentiating SU 5402's role in translational research.

• Systematic Evaluation of AKT Inhibitors Reveals Pharmacologi

  2026-05-02

  This study provides a detailed molecular and pharmacological comparison of ATP-competitive and allosteric AKT inhibitors, revealing distinct mechanisms of action, isoform-selective resistance, and new phosphoproteomic signatures. The findings refine our understanding of AKT inhibitor utility and inform rational design of combination therapies and research workflows.

• EZ Cap™ Firefly Luciferase mRNA: Optimizing LNP Delivery for

  2026-05-01

  Explore how EZ Cap™ Firefly Luciferase mRNA, featuring a Cap 1 structure, enables enhanced mRNA delivery and robust bioluminescent assays. This article uniquely connects lipid nanoparticle design with advanced reporter applications, backed by the latest nanobiotechnology research.

• Intestinal TM6SF2 Protects Against MASH via the Gut–Liver Ax

  2026-04-30

  This study establishes intestinal TM6SF2 as a critical safeguard against metabolic dysfunction-associated steatohepatitis (MASH) by preserving gut barrier integrity and modulating the gut microbiome. The findings reveal mechanistic links between TM6SF2 deficiency, intestinal lipid metabolism, microbial dysbiosis, and hepatic inflammation, suggesting new intervention points in metabolic liver disease.

• Reliability in Peptide Synthesis: HATU (A7022) for Amide For

  2026-04-30

  This article addresses persistent laboratory challenges in peptide synthesis chemistry, focusing on the role of HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) (SKU A7022). Through real-world scenarios and evidence-based best practices, we demonstrate how this coupling reagent from APExBIO enhances reproducibility, yield, and workflow confidence in biomedical research.

• PtrbZIP12 Enhances Drought Tolerance in Poplar via Direct Ta

  2026-04-29

  This study elucidates how the bZIP transcription factor PtrbZIP12 directly regulates drought resistance in Populus trichocarpa by activating PtrDHN and PtrPOD expression. It uncovers phosphorylation as a key modulator of PtrbZIP12 function, providing insight into plant stress adaptation and highlighting new avenues for protein phosphorylation analysis in plant signaling research.

• Salmonella Haem Biosynthesis Suppresses Macrophage Phagocyto

  2026-04-29

  This study uncovers a methyltransferase-mediated mechanism in Salmonella Typhimurium that enhances bacterial haem biosynthesis, thereby inhibiting macrophage phagocytosis and promoting virulence in mice. The findings highlight pathogen-derived haem as a critical modulator of host immune evasion, opening new avenues for dissecting bacterial strategies in host-pathogen interactions.

• I-BET151 (GSK1210151A): Protocols & Innovations in Cancer Bi

  2026-04-28

  I-BET151 (GSK1210151A) empowers precise dissection of BET-regulated transcriptional programs and cell fate in cancer research. This article spotlights experimental protocols, advanced use-cases, and troubleshooting strategies for maximizing the impact of this selective BET inhibitor.

• Distinct Mechanisms of Gepotidacin and Fluoroquinolones Targ

  2026-04-28

  This article reviews the mechanistic and structural insights from the study of gepotidacin’s inhibition of Staphylococcus aureus gyrase, highlighting how its mode of action diverges from traditional fluoroquinolone antibiotics. The findings inform future research on antibacterial strategies, especially in the context of rising fluoroquinolone resistance.

• Spiroplasma eriocheiris Entry: Clathrin-Mediated Endocytosis

  2026-04-27

  This study establishes Drosophila Schneider 2 (S2) cells as a model for Spiroplasma eriocheiris infection, revealing that entry relies on clathrin-mediated endocytosis and macropinocytosis. Functional inhibition experiments provide mechanistic evidence, with implications for dissecting endocytic pathways in host-pathogen interactions.

• Deep Learning Enables High-Content Cardiotoxicity Screening

  2026-04-27

  Grafton et al. introduce a scalable deep-learning approach to detect drug-induced cardiotoxicity using high-content imaging of iPSC-derived cardiomyocytes. This method allows rapid screening of diverse compound libraries, advancing cardiac safety assessment in early-stage drug discovery.

• MDL 28170 Calpain Inhibitor: Applied Workflows & Optimizatio

  2026-04-26

  MDL 28170, a highly selective calpain inhibitor from APExBIO, empowers translational research across neuroprotection, cardiac, and infectious disease models with robust, reproducible inhibition of cysteine proteases. This guide delivers evidence-driven protocol enhancements, troubleshooting strategies, and unique cross-domain insights for maximizing experimental impact.

• KIR2.1 Inhibition Reduces PASMC Proliferation via TGF-β/Smad

  2026-04-25

  This study demonstrates that KIR2.1 contributes to pulmonary artery smooth muscle cell (PASMC) proliferation and migration through activation of the TGF-β1/Smad2/3 pathway, a key process in pulmonary vascular remodeling. Targeting either KIR2.1 or TGF-β signaling with specific inhibitors like SB 431542 effectively reduced PASMC proliferation, suggesting potential therapeutic avenues for pulmonary hypertension.

460 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page